Investment Partner, Western Technology Investment
Jon joined WTI in 2013. He was founding partner of Foghorn Capital, a financial advisory firm. He was President and CFO of IPWireless, a venture backed wireless broadband company. He was CEO and CFO of iAsiaWorks, a venture backed data center company that he helped take public. He was CFO of Phoenix Network, a venture and private equity backed publicly traded telecom services company. Jon worked at TPG sourcing new investments and working with portfolio companies. He graduated from Harvard College Magna Cum Laude. He also holds an MBA from Stanford University.
Co-Editor-in-Chief, MedTech Strategist
David Cassak has more than 30 years of experience in the healthcare industry. Cassak co-founded Windhover Information Inc., and also served as Vice President, Content, and Managing Director, Medical Devices for Elsevier Business Intelligence, a Reed Elsevier Company which included the publications In Vivo, Startup, RPM Report, Medtech Insight, The Gray Sheet and The Pink Sheet.
Partner, Knobbe Martens
Paul N. Conover is a partner in Knobbe Martens’ Orange County, CA office. He leads teams of attorneys in strategically obtaining patents domestically and internationally, performing due diligence in transactions involving intellectual property, developing and implementing licensing strategies, performing market clearance and engineering design-around efforts, and enforcing patents and defending against patents in the pre-litigation stages. Mr. Conover works with clients in multiple areas of technology, including many types of medical devices, optics, and consumer products. He has spoken at many events on intellectual property topics, including in Brazil, India, and the United States. He has also published on many intellectual property topics, including regarding the recent decisions by the U.S. Supreme Court on patent law.
MD, Partner, Sante Ventures
James joined Santé Ventures in 2010. Previously, James served in the Air Force and was the medical director and Vice-Chair of Emergency Medicine at Wilford Hall Medical Center, an academic level-one trauma center in San Antonio. He completed two tours in Iraq as a critical care transport team chief and as the emergency department commander. He separated honorably as a Major in 2008. James received his MBA from the University of Texas McCombs School Of Business, his MD from Harvard Medical School, and a BS in bioengineering, Summa Cum Laude, from the University of Michigan. He is board certified in emergency medicine and completed his residency at Massachusetts General Hospital and Brigham and Women’s Hospital.
Vice President Corporate Development, Medtronic
Chris Eso is Vice President of Corporate Development for Medtronic, specifically covering the Cardiac and Vascular Group business units, including Cardiac Rhythm and Heart Failure (CRHF), Coronary and Structure Heart (CSH), and Aortic, Peripheral Vascular and endoVenous (APV). Chris has more than 18 years of successful professional experience with the majority of his experience in a business/corporate development and strategy capacity within the pharmaceutical and medical device industries, in addition to Medtronic, including Allergan, Watson, Agilent Technologies and Peregrine Pharmaceuticals
Peter J. Fitzgerald, MD, PhD
Professor of Medicine and Engineering; Director, Center for Cardiovascular Innovation, Stanford University Medical Center
Peter serves as the Director of the Interventional Cardiology Research Laboratory at Stanford Medical School. He has led or participated in numerous clinical trials for new medical devices and serves on the FDA Medical Device Advisory Panel. Peter has a PhD in biomedical engineering and has advised dozens of medical device startups and multinational healthcare companies in the design and development of new devices, diagnostics and therapies in cardiology, orthopedics, pulmonary disease, and other areas.
Partner, Lightstone Ventures
Hanson is a Venture Partner of LSV. He assists the LSV medical device team with deal sourcing, due diligence, and portfolio company management. He has served in this role since November 2013. Hanson is also currently a Managing Partner at the Foundry, LLC. The Foundry is the premier medical device company incubator and a preferred partner to LSV. Since its inception in 1998, The Foundry has founded and financed over a dozen medical device companies. Success stories include Ardian (acquired by Medtronic), eValve (acquired by Abbott), and Concentric (acquired by Stryker).
Innovation Manager, OLYMPUS Corporation
Dr. Kazuhiro Gono is a senior representative of Olympus’ new Technology Innovation office based in Tokyo. He is responsible for leading the company’s healthcare innovation strategy and technology scouting. Mr. Gono has 25 years of experience in medical device R&D, business development, HCP networking and technology scouting. He received his Ph.D in Biomedical Engineering from the Tokyo Institute of Technology in 2003.
Partner, Knobbe Martens
Curtis R. Huffmire is a partner in Knobbe Martens’ Orange County, CA office. His practice focuses on patent litigation, prosecution, counseling and licensing. He has experience in mechanical, medical, and electronic devices, systems and methods. Mr. Huffmire represents clients in a wide range of technologies, including medical devices and procedures, vehicle systems, surveillance systems, electro-mechanical systems, and materials engineering. Mr. Huffmire is a member of the litigation team representing clients in the enforcement of their intellectual property rights and responding to the allegations of their competitors. Mr. Huffmire also works with clients to obtain patent protection on their new products and ideas. His practice includes counseling clients regarding patent infringement, patent validity, licensing, and right-to-practice issues.
Vice President Business Development, Johnson & Johnson
Jennifer Kozak is Vice President, Business Development in Johnson & Johnson’s Medical Devices group. In this role, Jennifer is responsible for Business Development (BD) activities for New Growth Platforms. She also works to develop and lead new external innovation models and works with Johnson & Johnson Development Corporation to optimize our equity investment strategy and portfolio. Jennifer has led numerous BD projects and strategic assessments, including the strategy to enter the ENT (Ears, Nose, Throat) space leading to the acquisition of Acclarent, and the Angiotech knotless tissue closure device asset acquisition. She began her career at Johnson & Johnson as an engineer at Johnson & Johnson Interventional Systems prior to the merger with Cordis Corporation. While at Cordis, she held various roles in Operations, R&D and New Business Development. Following Cordis, she joined Ethicon, Inc. a Johnson & Johnson company in New Business Development responsible for New Growth Opportunities. Jennifer has a BS in Chemical Engineering from Bucknell University, and completed the Smith College Leadership Consortium Executive Education.
Partner, Knobbe Martens
Irfan A. Lateef serves clients around the globe with intellectual property matters, with particular emphasis in high stakes patent litigation. He appears regularly before federal district courts throughout the country and has extensive experience before the International Trade Commission in Section 337 proceedings. Irfan has obtained significant awards for plaintiffs and also efficiently defended his clients’ interests. He has succeeded at all levels of litigation including early settlement, motions for summary judgment, jury verdicts, and appeals. Irfan is also a registered patent attorney. He has prepared and prosecuted patent applications in a variety of technologies, including e-commerce, computer software, and medical devices. He also represents clients in other intellectual property matters including those involving patents, trademarks, trade secrets, trade dress and copyrights, with cases in areas such as electronics, semiconductors, biometric authentication, software, medical devices, and prosthesis technology.
Co-Editor-in-Chief and Managing Partner
Stephen served as Executive Editor & General Counsel at Windhover Information followed by Editor-in-Chief of Medical Devices for Elsevier Business Intelligence, where he directed the company’s editorial coverage of the medical device industry. Before that, Stephen was Senior Counsel to the US Senate Permanent Subcommittee on Investigations, where he directed Senate investigations into a wide variety of areas including health care fraud and abuse, international organized crime, and corruption in federal contracting programs, while also participating in other Senate investigations including the Whitewater inquiry. Before joining the Subcommittee, he was with the Federal Election Commission and the Department of Justice.
Allan W. May
Chairman, Founder, Life Science Angels
Allan is a founder of Life Science Angels, the largest and most well-known early-stage investment group focused solely on emerging biotech, medical device, diagnostic and mobile health companies (LSA). LSA was named the Top Angel Investment Group in the United States by industry analytical source CB Insights. LSA has invested over $60M in over 70 startups and has achieved 20 positive exits. Allan recently co-founded Woodside China Medical, a Suzhou China based incubator helping commercialize U.S. medical technologies in China. Allan was Managing Partner of Emergent Medical Partners Venture Fund, and has been founder, Chairman, CEO, or investor in over 100 medtech, biotech, and diagnostic startups. He was a co-founder and Chairman of Nanostim, developer of a Leadless Cardiac pacemaker, which was acquired by St. Jude Medical in 2013, and co-founder of Hyalex Surgical, Inc, developer of a novel artificial cartilage for total joint replacements.
CEO, iO Life Ventures
Rajan Patel is a medical device executive with extensive experience in diagnostics, critical care, patient monitoring, imaging, and lab products. During his 30+ year medical device-focused career, he led numerous Research & Development and manufacturing teams, successfully launching products to aid laboratory and health care professionals and improve patient care.
Founder and Managing Partner, McGeever, LLC, and acting President and CEO of SalesForce4Hire
Kevin Schimelfenig is the Founder and Managing Partner of McGeever, LLC and is acting President and CEO of SalesForce4Hire, a family office positioned to establish, administer and govern the financial and philanthropic values and goals of the family. McGeever’s investment portfolio includes but is not limited to; Healthcare, Real Estate, Energy, and Information Technology. Through McGeever, Kevin participates in investments with multiple Angel Funds and is a limited partner with Private Equity firms on the East and West Coast as well as has affiliations with well-known medical device and diagnostic institutions